Herder, G. J., H. Kramer, et al. (2006). "Traditional versus up-front [18F]
fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer:
a Dutch cooperative randomized study." J Clin Oncol 24(12): 1800-6.
HTBS, “Comment on NICE Technology Appraisal Guidance on the use of docetaxel,
paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer”
2001B.
Hunink, M et al, Decision making in Health and Medicine: Integrating evidence and
values, Cambrdige, C.U.P, 2001.
Keith, C. J., K. A. Miles, et al. (2002). "Solitary pulmonary nodules: accuracy and cost-
effectiveness of sodium iodide FDG-PET using Australian data." Eur J Nucl Med Mol
Imaging 29(8): 1016-23.
Kelly, R. F., T. Tran, et al. (2004). "Accuracy and cost-effectiveness of [18F]-2-fluoro-
deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small
cell lung cancer." Chest 125(4): 1413-23.
Kosuda, S., K. Ichihara, et al. (2002). "Decision-tree sensitivity analysis for cost-
effectiveness of whole-body FDG PET in the management of patients with non-small-cell
lung carcinoma in Japan." Ann Nucl Med 16(4): 263-71.
Miles, K. A. (2001). "An approach to demonstrating cost-effectiveness of diagnostic
imaging modalities in Australia illustrated by positron emission tomography." Australas
Radiol 45(1): 9-18.
National Institute of Health and Clinical Effectiveness, “The Diagnosis and treatment of
Lung Cancer; Methods, Evidence and Guidance. National Collaboration Centre of Acute
Care. 2005.
Nguyen, V. H., S. Peloquin, et al. (2005). "Cost-effectiveness of positron emission
tomography for the management of potentially operable non-small cell lung cancer in
Quebec" Canadian Respiratory Journal 12(1): 19-25.
Rosenthal, M. A., P. J. Webster, et al. (1992). "The cost of treating small cell lung
cancer." Med J Aust 156(9): 605-10.
Scott, W. J., J. Shepherd, et al. (1998). "Cost-effectiveness of FDG-PET for staging non-
small cell lung cancer: a decision analysis." Ann Thorac Surg 66(6): 1876-83; discussion
1883-5.
Sloka, J. S., P. D. Hollett, et al. (2004). "Cost-effectiveness of positron emission
tomography for non-small cell lung carcinoma in Canada." Med Sci Monit 10(5): MT73-
80.
van Tinteren, H., O. S. Hoekstra, et al. (2002). "Effectiveness of positron emission
tomography in the preoperative assessment of patients with suspected non-small-cell lung
cancer: the PLUS multicentre randomised trial." Lancet 359(9315): 1388-93.